Arena's Belviq scripts spike on DTC, stepped-up field force; Sanofi inks cancer marketing pact with India's Emcure;

> Arena Pharmaceuticals ($ARNA) reported a 43% rise in second-quarter sales of its obesity drug Belviq as DTC ads and a beefed-up sales force gained momentum. Report

> Sanofi ($SNY) tapped India's Emcure Pharmaceuticals to market its oncology drugs Taxotere, Jevtana, Fludara and Fasturtec in that country. Report

> It's official: Roche ($RHHBY) has won approval to market Avastin in Europe as a treatment for recurrent ovarian cancer resistant to platinum-based chemo. Release | Report

> Pfizer's ($PFE) Enbrel scored a European nod to treat a rare inflammatory joint disorder at early stages of the disease. Report

> Ashfield Healthcare recruited Wendy Wolf away from Publicis Touchpoint Solutions to be its SVP of commercial and clinical operations. Report

And Finally... A new scientific review found that aspirin could stave off bowel and stomach cancers. Report